RSTN | Reconstructive Surgery Trials Network
A National Audit of the Practice and Outcomes of Therapeutic MammaplastyThe TeaM Study Group on behalf of the Mammary Fold Academic and Research CollaborativeStudy Protocol Version 622nd May, 2016The TeaM StudyA national audit of the practice and outcomes of therapeutic mammaplastyTeaM Study Steering and Protocol Management GroupMiss Shweta AggarwalLocum Consultant Oncoplastic Breast SurgeonBarts Health NHS TrustWhipps Cross University Hospitaldrshweta@ Mr Naren BasuConsultant Oncoplastic Breast SurgeonQE Hospital BirminghamNaren_basu@Miss Elizabeth BakerST8 Breast SurgeryYorkshire and the Humber DeaneryProject Originator(elbaker@.uk)Mr Olivier BranfordConsultant Plastic SurgeonRoyal Marsden NHS Foundation TrustRSTN RepresentativeOlivier.branford@totalise.co.ukMiss Lisa BrockResearch Co-ordinatorNottingham Breast InstituteLisa.brock@nuh.nhs.ukMs Patricia FairbrotherIndependent Cancer Patients’ VoicePatient RepresentativePat@.ukMr Matthew GardinerClinical Lecturer, University of OxfordSpecialist Registrar in Plastic SurgeryMid Essex HospitalsRSTN Representativematthew.gardiner@kennedy.ox.ac.ukMiss Charlotte IvesST8, Breast SurgeryPenninsula DeaneryMammary Fold Academic and Research Collaborative RepresentativeCharlotte.ives@Professor Chris HolcombeProfessor of Breast SurgeryRoyal Liverpool HospitalABS Academic and Research Committee RepresentativeChris.Holcombe@rlbuht.nhs.ukMr Abhilash JainHEFCE Clinical Senior Lecturer in Plastic and Hand Surgery, University of Oxford, Honorary Consultant Plastic Surgeon, Imperial College Healthcare NHS TrustRCS SSL in Plastic and Hand Surgeryabhilash.jain@kennedy.ox.ac.ukMr Baek KimST6 Breast traineeYorkshire and the Humber DeaneryProject OriginatorMammary Fold Academic and Research Collaborative Representative (kimbaek@.uk)Mr R Douglas MacmillanConsultant Oncoplastic Breast SurgeonNottingham Breast InstituteCity HospitalSenior Protocol Advisordouglas.macmillan@nottingham.ac.ukMr John MurphyConsultant Oncoplastic Breast SurgeonUniversity Hospital South ManchesterSenior Protocol AdvisorJohn.Murphy@uhsm.nhs.ukMiss Shelley PotterAcademic Clinical LecturerCentre for Surgical ResearchUniversity of BristolShelley.potter@bristol.ac.ukMr Tim RattayNIHR Doctoral FellowDepartment of Cancer StudiesUniversity of Leicestertr104@leicester.ac.ukMr Dennis RemoundosConsultant Oncoplastic Breast SurgeonOxforddremoundos@Mr Richard SuttonConsultant Oncoplastic Breast SurgeonRoyal United Hospital Bath richardsutton@Mr Adam TrickeyResearch AssociateSchool of Social and Community Medicine, University of BristolStatistician and methodologyAdam.trickey@bristol.ac.ukMiss Kate WilliamsNational Oncoplastic FellowPresident, Mammary FoldUniversity Hospitals South Manchesterkwilliams@.uk Methodological SupportBristol Surgical Trials CentreSchool of Social and Community MedicineUniversity of Bristolcsr-bristol@bristol.ac.ukOn behalf of the Mammary Fold Academic Committee (mfac.research@)Website: themammaryfold/research-collaboratives-3/ContentsBackground...................................................................................................................1.1 Therapeutic mammaplasty........................................................................................1.2 Trainee research collaboratives................................................................................556Aims and objectives....................................................................................................6Definitions......................................................................................................................3.1 Therapeutic mammaplasty........................................................................................3.2 Clinical outcomes.....................................................................................................3.3 Oncological outcomes...............................................................................................7778Audit standards.............................................................................................................9Methods......................................................................................................................... 5.1 Hospital episode statistics analysis……………………………………………………... 5.2 Prospective audit………………………………………………………………………… 5.2.1 Logistical and clinical governance issues........................................................ 5.2.2 Patient inclusion and exclusion criteria........................................................... 5.2.3 Participant identification and recruitment........................................................5.3 Design of a multicentre cohort study……………………………………………………10101011121414Data collection...............................................................................................................15Data validation and quality assurance……………………………………..…………….Data management and storage....................................................................................2425Sample size and data analysis....................................................................................8.1 HES Analysis………………………………………………………………………………8.2 Prospective audit…………………………………………………………………………..8.2.1 Sample size......................................................................................................8.2.2 Data analysis....................................................................................................2626262626Publication and authorship policy..............................................................................9.1 Citable collaborators.................................................................................................9.2 Acknowledged collaborators.....................................................................................272828Research governance...................................................................................................28Study management.......................................................................................................28Study time lines............................................................................................................12.1 Study Gantt chart..................................................................................................References.....................................................................................................................2930311.Background1.1Therapeutic mammaplastyBreast conserving surgery (BCS) and adjuvant radiotherapy is an established treatment for early breast cancerPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GaXNoZXI8L0F1dGhvcj48WWVhcj4yMDAyPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5GaXNoZXI8L0F1dGhvcj48WWVhcj4yMDAyPC9ZZWFyPjxS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ADDIN EN.CITE.DATA 1, 2. While many women may prefer breast conservation to mastectomy, in many cases, standard BCS may result in unacceptable cosmetic outcomes ADDIN EN.CITE <EndNote><Cite><Author>Haloua</Author><Year>2014</Year><RecNum>2212</RecNum><DisplayText><style face="superscript">3</style></DisplayText><record><rec-number>2212</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1448366075">2212</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Haloua, MH</author><author>Krekel, NMA</author><author>Jacobs, GJA,</author><author>Zonderhuis, B</author><author>Bouman, MB</author><author>Buncamper, ME</author><author>Niessen, FB</author><author>Winters HAH</author><author>Terwee, Caroline</author><author>Meijer, S</author><author>van den Tol, MP</author></authors></contributors><titles><title>Cosmetic assessment following breast conserving therapy: A comparison between BCCT.core software and panel evaluation</title><secondary-title>International Journal of Breast Cancer</secondary-title></titles><periodical><full-title>International Journal of Breast Cancer</full-title></periodical><volume>Article ID 716860</volume><dates><year>2014</year></dates><urls></urls><electronic-resource-num>10.1155/2014/716860</electronic-resource-num></record></Cite></EndNote>3 which may adversely impact on patient satisfaction and quality of life ADDIN EN.CITE <EndNote><Cite><Author>Cochrane</Author><Year>2003</Year><RecNum>2211</RecNum><DisplayText><style face="superscript">4</style></DisplayText><record><rec-number>2211</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1448296069">2211</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Cochrane, R. A.</author><author>Valasiadou, P.</author><author>Wilson, A. R. M.</author><author>Al-Ghazal, S. K.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised</title><secondary-title>British Journal of Surgery</secondary-title></titles><periodical><full-title>British Journal of Surgery</full-title></periodical><pages>1505-1509</pages><volume>90</volume><number>12</number><dates><year>2003</year></dates><publisher>John Wiley & Sons, Ltd.</publisher><isbn>1365-2168</isbn><urls><related-urls><url>. Therapeutic mammaplasty (TM) describes ‘the oncoplastic application of breast reduction and mastopexy techniques to treat selected breast cancers by breast conserving surgery (BCS)’ ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5, 6</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url> app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447433081">2206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Macmillan, D</author><author>James, R</author><author>Gale, KL</author><author>McCulley, S. J.</author></authors></contributors><titles><title>Therapeutic mammoplasty</title><secondary-title>Journal of Surgical Oncology</secondary-title></titles><periodical><full-title>Journal of Surgical Oncology</full-title></periodical><pages>90-95</pages><volume>110</volume><section>90</section><dates><year>2014</year></dates><urls></urls></record></Cite></EndNote>5, 6. These techniques effectively extend the boundaries of traditional BCS by allowing adequate resection of larger tumours in women with medium to large breasts without compromising cosmetic outcomePEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW5zZmllbGQ8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFy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=
ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NYW5zZmllbGQ8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFy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=
ADDIN EN.CITE.DATA 7-10; provide an alternative to mastectomy +/- reconstruction in those with ptotic breasts ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url> and may improve outcomes for women with large breasts in whom standard BCS followed by radiotherapy may be associated with lymphoedema, fibrosis and chronic pain ADDIN EN.CITE <EndNote><Cite><Author>McIntosh</Author><Year>2012</Year><RecNum>3</RecNum><DisplayText><style face="superscript">11</style></DisplayText><record><rec-number>3</rec-number><foreign-keys><key app="EN" db-id="5svtpsv0r5e2rbe0f9ov5arbtat0r0ttwata">3</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McIntosh, J.</author><author>O'Donoghue, J. M.</author></authors></contributors><auth-address>Department of Plastic Surgery, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, United Kingdom. doctormcintosh@</auth-address><titles><title>Therapeutic mammaplasty--a systematic review of the evidence</title><secondary-title>Eur J Surg Oncol</secondary-title><alt-title>European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology</alt-title></titles><pages>196-202</pages><volume>38</volume><number>3</number><keywords><keyword>Breast Neoplasms/pathology/*surgery</keyword><keyword>Esthetics</keyword><keyword>Female</keyword><keyword>Humans</keyword><keyword>Mammaplasty/*methods</keyword><keyword>Outcome Assessment (Health Care)</keyword><keyword>Patient Satisfaction</keyword><keyword>Postoperative Complications</keyword></keywords><dates><year>2012</year><pub-dates><date>Mar</date></pub-dates></dates><isbn>1532-2157 (Electronic)
0748-7983 (Linking)</isbn><accession-num>22206704</accession-num><urls><related-urls><url>. Despite the widespread adoption of these techniques into routine practice, there is limited high-quality evidence to support benefits of this approach. TM procedures are more complex than standard BCS with significant associated resource implications and concerns have been raised regarding both complication rates and oncological safety when TM is performed. Although these concerns are not supported by the literaturePEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJ2ZXk8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5IYXJ2ZXk8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxS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ADDIN EN.CITE.DATA 12, 13, the majority of published studies are small, retrospective single centre, often single surgeon case series with limited follow-up that are poorly designed and reported with inconsistent end-points ADDIN EN.CITE <EndNote><Cite><Author>Schaverien</Author><Year>2014</Year><RecNum>2203</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>2203</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447410637">2203</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schaverien, M. V.</author><author>Doughty, J. C.</author><author>Stallard, S.</author></authors></contributors><titles><title>Quality of information reporting in studies of standard and oncoplastic breast-conserving surgery</title><secondary-title>The Breast</secondary-title></titles><periodical><full-title>The Breast</full-title></periodical><pages>104-111</pages><volume>23</volume><number>2</number><keywords><keyword>Breast-conserving surgery</keyword><keyword>Oncoplastic</keyword><keyword>Outcomes</keyword><keyword>Systematic review</keyword></keywords><dates><year>2014</year></dates><isbn>0960-9776</isbn><urls><related-urls><url> that limit cross-study comparison such that the findings cannot be relied upon. Two recent systematic reviewsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY0ludG9zaDwvQXV0aG9yPjxZZWFyPjIwMTI8L1llYXI+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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5NY0ludG9zaDwvQXV0aG9yPjxZZWFyPjIwMTI8L1llYXI+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ADDIN EN.CITE.DATA 11, 15 have highlighted the paucity of high-quality clinical, oncological and cosmetic outcome data and emphasised the urgent need for well-designed prospective studies to establish the indications and outcomes of therapeutic mammaplasty to determine best practice. Uncertainties relating to the current indications for TM including the practice and outcomes of TM in large tumours (>4cm) not traditional managed by BCS; rates and management of margin positivity; predictors of adverse outcomes; the impact of TM on delivery of adjuvant therapy and appropriate assessment of key patient reported outcomes including, but not limited to, aesthetic end-points, as well as long term data on recurrence rates in particular need to be addressed if the procedure is to be offered and bench-marked appropriately. Although RCTs provide the best evidence for the effectiveness of an intervention, trials are largely inappropriate in this context. A high-quality prospective multicentre cohort study exploring the practice and outcomes of these techniques is therefore essential to support the safe practice of TM, generate guidelines, guide decision-making and inform health policy. 1.2Trainee research collaborativesThere are a number of established barriers to the conduct of large prospective multicentre studies, but the trainee research collaborative model has emerged as a time and cost-effective means of conducting large-scale prospective research and audit in surgeryPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CaGFuZ3U8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CaGFuZ3U8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS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ADDIN EN.CITE.DATA 16, 17. Trainee collaboratives have an excellent track record in the design and delivery of well-designed prospective cohort studiesPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Db2xsYWJvcmF0aXZlPC9BdXRob3I+PFllYXI+MjAxNDwv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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Db2xsYWJvcmF0aXZlPC9BdXRob3I+PFllYXI+MjAxNDwv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ADDIN EN.CITE.DATA 18-20 and randomised clinical trialsPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CaGFuZ3U8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5CaGFuZ3U8L0F1dGhvcj48WWVhcj4yMDEzPC9ZZWFyPjxS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ADDIN EN.CITE.DATA 21, 22 in general surgery including the national appendicectomy audit which recruited 3326 patients from 95 centres over 2 months and the ROSSINI trial which randomised 760 patients from 21 centres to a wound protection device versus standard care. The trial recruited ahead of schedule and had minimal loss to follow-up ADDIN EN.CITE <EndNote><Cite><Author>Pinkney</Author><Year>2013</Year><RecNum>2056</RecNum><DisplayText><style face="superscript">22</style></DisplayText><record><rec-number>2056</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1389018710">2056</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Thomas D Pinkney</author><author>Melanie Calvert</author><author>David C Bartlett</author><author>Adrian Gheorghe</author><author>Val Redman</author><author>George Dowswell</author><author>William Hawkins</author><author>Tony Mak</author><author>Haney Youssef</author><author>Caroline Richardson</author><author>Steven Hornby</author><author>Laura Magill</author><author>Richard Haslop</author><author>Sue Wilson</author><author>Dion Morton</author></authors></contributors><titles><title>Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial)</title><secondary-title>BMJ</secondary-title></titles><periodical><full-title>BMJ</full-title></periodical><volume>347</volume><dates><year>2013</year><pub-dates><date>2013-07-31 16:18:57</date></pub-dates></dates><urls><pdf-urls><url>. Recent successes with iBRA (implant Breast Reconstruction evAluation Study)PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qb3R0ZXI8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxS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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5Qb3R0ZXI8L0F1dGhvcj48WWVhcj4yMDE0PC9ZZWFyPjxS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ADDIN EN.CITE.DATA 23, 24 and MasDA (Mastectomy Decisions Audit) have demonstrated that the methodology is both feasible and effective within the context of breast surgery. The TeaM (Therapeutic Mammaplasty) Study therefore aims to work with the Mammary Fold Academic and Research Collaborative (MFAC) trainee network to deliver a high-quality prospective audit of the practice and outcomes of TM in the UK.Aims and objectivesTo identify the number of units performing TM across the UK and the volumes of procedures performedTo describe the current practice of therapeutic mammaplasty (TM) including the indications and techniques used To evaluate the clinical outcomes of TM using different techniques and explore predictors of adverse outcome.To determine the impact of TM on the delivery of adjuvant therapyTo determine best practice with regards to TM with a view to generating national guidelines To establish a network of units performing TM willing and able to participate in future research studiesTo inform the feasibility, design and conduct of a prospective multicentre cohort study exploring the clinical, patient-reported and oncological outcomes of TMDefinitions3.1 Therapeutic mammaplastyFor the purpose of this study, ‘therapeutic mammaplasty’ will be defined as ‘the application of breast reduction or mastopexy techniques to treat selected breast cancers by breast conserving surgery.’ ADDIN EN.CITE <EndNote><Cite><Author>Macmillan</Author><Year>2014</Year><RecNum>2206</RecNum><DisplayText><style face="superscript">6</style></DisplayText><record><rec-number>2206</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447433081">2206</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Macmillan, D</author><author>James, R</author><author>Gale, KL</author><author>McCulley, S. J.</author></authors></contributors><titles><title>Therapeutic mammoplasty</title><secondary-title>Journal of Surgical Oncology</secondary-title></titles><periodical><full-title>Journal of Surgical Oncology</full-title></periodical><pages>90-95</pages><volume>110</volume><section>90</section><dates><year>2014</year></dates><urls></urls></record></Cite></EndNote>6 A therapeutic mammaplasty will always involve some degree of skin excision and reduction of the skin envelope. Level one oncoplastic procedures involving glandular remodelling with or without nipple re-positioning following wide local excision will be excluded.3.2Clinical outcomesThe following definitions of complications also will be used for this audit. Seroma - A symptomatic collection of fluid requiring aspiration. Haematoma - A collection of blood following the TM procedureMinor – managed conservatively by aspiration in clinic or Major – requiring surgical evacuation.Infection - A hot, red swollen breast associated with one of the following; a temperature, pus at the wound site, a raised white cell count; a positive wound culture within the first 30 days following surgery. This will be further classified as: Minor – requiring oral antibiotics only; Major 1 – requiring admission for IV antibiotics and/or debridement; Major 2 – requiring surgical drainage/debridementSkin necrosis - any area of skin loss on the operated breast including T junctionMinor – managed conservatively with dressings Major – requiring surgical debridement under general anaesthesia (GA) Wound dehiscence – separation of skin edges at any of the wound sites Minor – treated conservatively; Major – requiring return to theatre Nipple necrosis – Any area of necrosis of the nipple areolar complex (NAC) Minor – managed conservatively with dressings; Major 1 – requiring surgical debridement under GA; Major 2 – complete nipple lossIn hospital complication – any complication that occurs during the patient’s initial hospital stay at the time of their TM. This includes systematic complications such as DVT/PE and procedure specific complications such as haematoma.Readmission to hospital – any re-admission to hospital in 30 days following surgery directly related to the procedure (e.g with infection requiring antibiotics or systemic complications including pulmonary embolus)Return to theatre – Return to the operating theatre at any time during the first 30 days following surgery to deal with any complication of the TM.Major complication - Any complication requiring readmission to hospital or return to theatreMinor complication - Any other complication3.3 Oncological outcomesThe following definitions of outcomes related to oncological safety will be used:Positive margins – invasive tumour or DCIS at or close to resection margin requiring further surgery (re-excision of margins or completion mastectomy) as defined by local MDT policy (e.g. tumour at ink/<1mm/<2mm) Re-excision of margins – the removal of additional tissue in a second operation due to one or more involved margins as recommended by the MDT Completion mastectomy – removal of all of remaining breast tissue in a second procedure due to involved margin(s) as recommended by MDT or elected by patient choiceTime to adjuvant therapy – time from last surgery to delivery of 1st adjuvant therapy (radiotherapy or chemotherapy). Delay to adjuvant therapy - time to adjuvant therapy exceeds 31 days from last procedure ADDIN EN.CITE <EndNote><Cite><Author>National Institute of Clinical</Author><Year>2009</Year><RecNum>664</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>664</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1327229221">664</key><key app="ENWeb" db-id="SUZR4QrtqgYAADeSYrs">972</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>National Institute of Clinical, Excellence</author></authors></contributors><titles><title>Breast cancer (early & locally advanced): diagnosis and treatment</title></titles><volume>Clinical guidelines CG80</volume><reprint-edition>NOT IN FILE</reprint-edition><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>25.Audit standardsThere are currently no guidelines specific for the practice of therapeutic mammaplasty in the UK. Therapeutic mammaplasty, however, can be considered within the spectrum of ‘oncoplastic breast surgery’. The joint Association of Breast Surgery (ABS) and British Association of Plastic Reconstructive and Aesthetic Surgeons (BAPRAS) Oncoplastic Breast Reconstruction: Guidelines for Best Practice ADDIN EN.CITE <EndNote><Cite><Author>Rainsbury</Author><Year>2012</Year><RecNum>2058</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>2058</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1389784317">2058</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>Rainsbury, D</author><author>Willett, A</author></authors><secondary-authors><author>Rainsbury, R.</author><author>Willett, A</author></secondary-authors></contributors><titles><title>Oncoplastic Breast Reconstruction: Guidelines for Best Practice</title></titles><dates><year>2012</year></dates><publisher>ABS and BAPRAS</publisher><urls></urls></record></Cite></EndNote>26 have been developed to ‘establish key elements of best practice in the management of patients considering reconstructive oncoplastic breast surgery (OPBS), using established techniques to reconstruct the breast after total mastectomy or after partial mastectomy to prevent deformity following breast conservation ADDIN EN.CITE <EndNote><Cite><Author>Rainsbury</Author><Year>2012</Year><RecNum>2058</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>2058</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1389784317">2058</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>Rainsbury, D</author><author>Willett, A</author></authors><secondary-authors><author>Rainsbury, R.</author><author>Willett, A</author></secondary-authors></contributors><titles><title>Oncoplastic Breast Reconstruction: Guidelines for Best Practice</title></titles><dates><year>2012</year></dates><publisher>ABS and BAPRAS</publisher><urls></urls></record></Cite></EndNote>26.’ It is therefore appropriate to apply relevant quality criteria from this guidance to the current audit. Additional standards relating to the maximum numbers of procedures that should be performed in women undergoing BCS ADDIN EN.CITE <EndNote><Cite><Author>Association of Breast Surgery at</Author><Year>2009</Year><RecNum>2210</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>2210</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447594151">2210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Association of Breast Surgery at, Baso</author></authors></contributors><titles><title>Surgical guidelines for the management of breast cancer</title><secondary-title>European Journal of Surgical Oncology (EJSO)</secondary-title></titles><periodical><full-title>European Journal of Surgical Oncology (EJSO)</full-title></periodical><pages>S1-S22</pages><volume>35, Supplement 1</volume><dates><year>2009</year></dates><isbn>0748-7983</isbn><urls><related-urls><url> and timing of the delivery of adjuvant therapy ADDIN EN.CITE <EndNote><Cite><Author>National Institute of Clinical</Author><Year>2009</Year><RecNum>664</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>664</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1327229221">664</key><key app="ENWeb" db-id="SUZR4QrtqgYAADeSYrs">972</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>National Institute of Clinical, Excellence</author></authors></contributors><titles><title>Breast cancer (early & locally advanced): diagnosis and treatment</title></titles><volume>Clinical guidelines CG80</volume><reprint-edition>NOT IN FILE</reprint-edition><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>25 following breast surgery produced by the professional associations ADDIN EN.CITE <EndNote><Cite><Author>Association of Breast Surgery at</Author><Year>2009</Year><RecNum>2210</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>2210</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447594151">2210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Association of Breast Surgery at, Baso</author></authors></contributors><titles><title>Surgical guidelines for the management of breast cancer</title><secondary-title>European Journal of Surgical Oncology (EJSO)</secondary-title></titles><periodical><full-title>European Journal of Surgical Oncology (EJSO)</full-title></periodical><pages>S1-S22</pages><volume>35, Supplement 1</volume><dates><year>2009</year></dates><isbn>0748-7983</isbn><urls><related-urls><url> and National Institute of Health and Care Excellence (NICE) ADDIN EN.CITE <EndNote><Cite><Author>National Institute of Clinical</Author><Year>2009</Year><RecNum>664</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>664</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1327229221">664</key><key app="ENWeb" db-id="SUZR4QrtqgYAADeSYrs">972</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>National Institute of Clinical, Excellence</author></authors></contributors><titles><title>Breast cancer (early & locally advanced): diagnosis and treatment</title></titles><volume>Clinical guidelines CG80</volume><reprint-edition>NOT IN FILE</reprint-edition><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>25 respectively will also be applied. Unplanned return to theatre for local complications<5% of patients return to theatre for local complication (wound infection, wound problems requiring debridement or haematoma requiring evacuation)(QC16) ADDIN EN.CITE <EndNote><Cite><Author>Rainsbury</Author><Year>2012</Year><RecNum>2058</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>2058</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1389784317">2058</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>Rainsbury, D</author><author>Willett, A</author></authors><secondary-authors><author>Rainsbury, R.</author><author>Willett, A</author></secondary-authors></contributors><titles><title>Oncoplastic Breast Reconstruction: Guidelines for Best Practice</title></titles><dates><year>2012</year></dates><publisher>ABS and BAPRAS</publisher><urls></urls></record></Cite></EndNote>26Assessed prospectively and by review of notes at 30 days.Unplanned readmission5% of patients require re-admission to hospital within 3 months (QC17) ADDIN EN.CITE <EndNote><Cite><Author>Rainsbury</Author><Year>2012</Year><RecNum>2058</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>2058</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1389784317">2058</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>Rainsbury, D</author><author>Willett, A</author></authors><secondary-authors><author>Rainsbury, R.</author><author>Willett, A</author></secondary-authors></contributors><titles><title>Oncoplastic Breast Reconstruction: Guidelines for Best Practice</title></titles><dates><year>2012</year></dates><publisher>ABS and BAPRAS</publisher><urls></urls></record></Cite></EndNote>26As any complications from TM requiring re-admission are unlikely to occur after 30 days, this time frame will be used for the purpose of this audit. Unplanned readmission will be assessed prospectively and by review of notes at 30 days.Re-excision of marginsTo minimise the number of therapeutic operations, 100% of patients should have 3 or fewer procedures ADDIN EN.CITE <EndNote><Cite><Author>Association of Breast Surgery at</Author><Year>2009</Year><RecNum>2210</RecNum><DisplayText><style face="superscript">27</style></DisplayText><record><rec-number>2210</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447594151">2210</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Association of Breast Surgery at, Baso</author></authors></contributors><titles><title>Surgical guidelines for the management of breast cancer</title><secondary-title>European Journal of Surgical Oncology (EJSO)</secondary-title></titles><periodical><full-title>European Journal of Surgical Oncology (EJSO)</full-title></periodical><pages>S1-S22</pages><volume>35, Supplement 1</volume><dates><year>2009</year></dates><isbn>0748-7983</isbn><urls><related-urls><url>. Number of procedures to be assessed and recorded prospectively.Delivery of adjuvant therapy‘Start adjuvant chemotherapy or radiotherapy as soon as clinically possible within 31 days of completion of surgery.’ Delivery of adjuvant therapy more than 31 days following the completion of surgery (TM or excision of margins, if required) will be considered ‘a delay’ ADDIN EN.CITE <EndNote><Cite><Author>National Institute of Clinical</Author><Year>2009</Year><RecNum>664</RecNum><DisplayText><style face="superscript">25</style></DisplayText><record><rec-number>664</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1327229221">664</key><key app="ENWeb" db-id="SUZR4QrtqgYAADeSYrs">972</key></foreign-keys><ref-type name="Book">6</ref-type><contributors><authors><author>National Institute of Clinical, Excellence</author></authors></contributors><titles><title>Breast cancer (early & locally advanced): diagnosis and treatment</title></titles><volume>Clinical guidelines CG80</volume><reprint-edition>NOT IN FILE</reprint-edition><dates><year>2009</year></dates><urls></urls></record></Cite></EndNote>25. To be assessed prospectively.MethodsThis is a trainee collaborative project which will be co-ordinated by the Mammary Fold Academic and Research Collaborative (MFAC) Committee.The study will have 3 phasesExploration of trends in the national practice of TM using Hospital Episode Statistics (HES) data A multicentre prospective audit of the clinical outcomes of TMDesign of a multicentre cohort study Hospital episode statistics analysisThe provision of TM across the UK will be explored using Hospital Episode Statistics (HES) data. Data will be extracted regarding the numbers of TM procedures performed between 2005 and 2015 on a national and individual unit basis. Data will also be extracted regarding the numbers of mastectomies with and without immediate breast reconstruction that are performed over the same period. Variation in OPCS Classification of Interventions and Procedures coding for TM will be explored. The aims of this phase of the study will be to:Investigate variations in the provision of TM across the UKExplore how the provision of TM and the numbers performed have varied over time, nationally and by TrustExplore whether the introduction of TM procedures have led to a reduction in local mastectomy rates (+/- immediate breast reconstruction) compared with units in which the procedures are not offeredInvestigate how TM procedures are coded by individual unitsIdentify units performing TM to target for inclusion in the prospective audit phase of the study. 5.2Prospective auditAny breast or plastic surgical unit performing TM as defined by the application of breast reduction or mastopexy techniques to treat breast cancer using BCS will be eligible to participate in the audit. Units will be invited to participate through the Association of Breast Surgery, the Mammary Fold, the Association of Surgeons in Training (ASiT), the Reconstructive Surgery Trials Network (RSTN), the British Association of Plastic Reconstructive and Aesthetic Surgeons and the national research collaborative network. Units identified through phase 1 as performing high volumes of TM (>20/year) will also be specifically targeted for inclusion in the study by the steering group.A local study lead, ideally a senior trainee with an interest in breast surgery will be identified at each centre. In units without trainees, the unit lead can be any regular member of the surgical team (e.g a clinical nurse specialist; Speciality or Associate Specialist (SAS) doctor, research team, breast or plastic surgical consultant). If the lead is a trainee, they will be required to identify a supervising consultant to act as principal investigator (PI) for the study. Unit leads will responsible for obtaining the support of other members of the team. Support will also be sought from the professional associations – the Association of Breast Surgery (ABS) and the British Association of Plastic and Reconstructive Surgery (BAPRAS). We will ask that they encourage all Consultant members who are carrying out TM to support their trainees in this audit and to enter all patients undergoing TM in to the study as per ‘Guidelines for Best Practice’ quality criteria 22 ADDIN EN.CITE <EndNote><Cite><Author>Rainsbury</Author><Year>2012</Year><RecNum>2058</RecNum><DisplayText><style face="superscript">26</style></DisplayText><record><rec-number>2058</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1389784317">2058</key></foreign-keys><ref-type name="Report">27</ref-type><contributors><authors><author>Rainsbury, D</author><author>Willett, A</author></authors><secondary-authors><author>Rainsbury, R.</author><author>Willett, A</author></secondary-authors></contributors><titles><title>Oncoplastic Breast Reconstruction: Guidelines for Best Practice</title></titles><dates><year>2012</year></dates><publisher>ABS and BAPRAS</publisher><urls></urls></record></Cite></EndNote>26.5.2.1Logistical and clinical governance issuesPhase 2 is a clinical audit. The unit lead will be responsible for registering their unit with the TeaM study team (via mfacteamstudy@); obtaining local audit approvals for study participation and forwarding a copy of the approvals to the TeaM study team prior to the study start date (5th September 2016).If the unit lead is a trainee, the named supervising consultant will act as the principal investigator for the unit for registration purposes. Patient recruitment and data collection will be completed by the unit lead. It is anticipated that each unit lead will identify a small team of 2-3 people to help conduct the audit and will liaise with the wider team including oncologists and breast care and reconstructive nurses.The study will be piloted in two to three centres (Bath/Nottingham/Manchester) prior to national roll-out of the audit to evaluate the acceptability and completeness of data collection pro-formas and methods of data management.5.2.2Patient inclusion and exclusion criteriaInclusion criteriaAll female patients over the age of 16 under the care of either a breast or plastic surgeon undergoing a therapeutic mammaplasty defined as the application of breast reduction or mastopexy techniques including removal of skin to reduce the skin envelope to treat invasive or pre-invasive (DCIS) breast cancer using BCS will be eligible for inclusion in the study. This will include any of the following techniques, performed using appropriate glandular or dermoglandular pedicles at the time of tumour removal including the removal of skin to simultaneously reduce the skin envelope (figure 1):Wise pattern, ‘inverted T’ or inverted anchor reduction patterns Single vertical scar or LeJour reduction mammaplasty techniques Benelli mastopexyRound block or donut techniques with excision of skin (see figure)Grisotti flaps for central cancers removing the nippleMelon-slice or horizontal wedge excision with or without nipple preservationExclusion criteriaThe following patients will be excluded:i. Women undergoing standard BCS not using reduction or mastopexy techniques with removal of skin to reduce the skin envelopeii.Women undergoing BCS involving glandular remodelling only with or without nipple recentralisation (Level 1 techniques)iii.Women undergoing BCS combined with volume replacement procedures such as LD mini-flaps, TDAP or LICAP flapsiv.Women undergoing breast reduction or mastopexy to improve the appearance of the breast in a separate procedure from the initial resection of the tumour.v.Women undergoing mastectomy with or without immediate reconstructionv. Women undergoing surgery for indications other than invasive or pre-invasive diseaseFigure 1 – Types of therapeutic mammaplasty Wise pattern, inverted T or anchor reduction pattern techniques ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url> vertical scar or LeJour reduction mammaplasty techniques ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url> mastopexy techniqueRound block or donut technique ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url> from ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url> flap ADDIN EN.CITE <EndNote><Cite><Author>Grisotti</Author><Year>1994</Year><RecNum>2236</RecNum><DisplayText><style face="superscript">28</style></DisplayText><record><rec-number>2236</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1453651413">2236</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Grisotti, A.</author></authors></contributors><titles><title>Immediate reconstruction after partial mastectomy</title><secondary-title>Operative Techniques in Plastic and Reconstructive Surgery</secondary-title></titles><periodical><full-title>Operative Techniques in Plastic and Reconstructive Surgery</full-title></periodical><pages>1-12</pages><volume>1</volume><number>1</number><keywords><keyword>segmental mastectomy</keyword><keyword>quadrantectomy</keyword><keyword>tumorectomy</keyword></keywords><dates><year>1994</year><pub-dates><date>5//</date></pub-dates></dates><isbn>1071-0949</isbn><urls><related-urls><url>(10)80013-7</electronic-resource-num></record></Cite></EndNote>28 for central tumours excising the nippleMelon slice or horizontal wedge excision (may or may not include nipple)111006455659500 49163369155100Adapted from ADDIN EN.CITE <EndNote><Cite><Author>McCulley</Author><Year>2005</Year><RecNum>2204</RecNum><DisplayText><style face="superscript">5</style></DisplayText><record><rec-number>2204</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447432694">2204</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>McCulley, S. J.</author><author>Macmillan, R. D.</author></authors></contributors><titles><title>Planning and use of therapeutic mammoplasty—Nottingham approach</title><secondary-title>British Journal of Plastic Surgery</secondary-title></titles><periodical><full-title>British Journal of Plastic Surgery</full-title></periodical><pages>889-901</pages><volume>58</volume><number>7</number><keywords><keyword>Breast cancer</keyword><keyword>Breast conserving surgery</keyword><keyword>Reduction</keyword><keyword>Mammaplasty</keyword><keyword>Therapeutic mammaplasty</keyword></keywords><dates><year>2005</year></dates><isbn>0007-1226</isbn><urls><related-urls><url>. Participant identification and recruitmentIt is expected that participating centres will recruit consecutive patients into the audit. The completeness of case ascertainment will be determined by comparing numbers of patients recruited with HES data from the same period and by independent validation of procedure numbers in selected sites. Any disparity will be explored with the unit concerned and any unit determined to have recruited patients selectively will be excluded from the analysis (see QA section).Potential participants will be identified prospectively by the local audit team via clinics, local MDTs, consultant surgeons and clinical nurse specialists. Simple demographic, procedure and process data collected will be contemporaneously for each participant. Data will be recorded in an anonymised format using a unique alphanumeric study identification number on a secure web-based database (REDCap) designed by Vanderbilt UniversityPEVuZE5vdGU+PENpdGU+PEF1dGhvcj5PYmVpZDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE PEVuZE5vdGU+PENpdGU+PEF1dGhvcj5PYmVpZDwvQXV0aG9yPjxZZWFyPjIwMTM8L1llYXI+PFJl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ADDIN EN.CITE.DATA 29, 30 (). Data regarding in hospital complications will be collected prospectively and patients will be reviewed in clinic at 30 days to collect complication and oncology data. Note review will be performed in patients who do not attend for 30 day follow-up.Design of multicentre cohort studyData from phases 1 and 2 will be used to inform the design and conduct of a definitive multicentre cohort study. Specifically, the TeaM study will establish the number and locations of units performing TM (to inform recruitment); the volumes of TMs performed (to inform sample size and feasibility of recruitment); the indications for surgery (to inform inclusion criteria); the techniques used (to inform study design and sample size); the short-term clinical outcomes (to inform choice of primary and secondary outcomes and sample size) and the timing of contralateral surgery (to inform the timing of PROMs assessments). Candidate study designs and outcomes will be explored with patient focus group to ensure the final study is acceptable and valuable to patients. Data collectionThe following data set will be collected prospectively based on relevant criteria outlined by Schaverien et al ADDIN EN.CITE <EndNote><Cite><Author>Schaverien</Author><Year>2014</Year><RecNum>2203</RecNum><DisplayText><style face="superscript">14</style></DisplayText><record><rec-number>2203</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1447410637">2203</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Schaverien, M. V.</author><author>Doughty, J. C.</author><author>Stallard, S.</author></authors></contributors><titles><title>Quality of information reporting in studies of standard and oncoplastic breast-conserving surgery</title><secondary-title>The Breast</secondary-title></titles><periodical><full-title>The Breast</full-title></periodical><pages>104-111</pages><volume>23</volume><number>2</number><keywords><keyword>Breast-conserving surgery</keyword><keyword>Oncoplastic</keyword><keyword>Outcomes</keyword><keyword>Systematic review</keyword></keywords><dates><year>2014</year></dates><isbn>0960-9776</isbn><urls><related-urls><url> demographicsCentre name and study IDAge (years)Height (m)Weight (kg)BMIBra sizeSternal notch to nipple distance (cm)Smoking status (non-smoker, ex-smoker >6/12, ex-smoker <4/52, current smoker, nicotine replacement)Diabetes (no/yes) Ischaemic heart disease (angina/previous MI) yes/noConnective tissue disease (e.g. SLE) yes/noCurrent steroid therapy (yes/no)Other comorbidities (free text box)Prior and neoadjuvant treatmentsPrevious radiotherapy to breast/chest wall (yes/no) with side if yesNeoadjuvant chemotherapy (yes/no)Neoadjuvant endocrine therapy (yes/no)Previous surgery to breast - (none/wide local excision/augmentation/reduction/other – please state) (date month/yearPre-operative planning dataInitial presentation Screening or symptomaticBreast affectedRight/left/bilateralFor each affected breast3.3Predominant location of tumour, by quadrant Upper outerUpper innerLower innerLower outerCentral (immediately behind or involving the nipple)3.4Type of lesionDuctal carcinoma in situ only, Invasive ductal cancer, Invasive lobular cancer, Other3.5Grade of cancer (1/2/3) or DCIS (low/intermediate/high)3.6Maximum size of lesion on pre-operative imaging in 2 dimensions (mm) x (mm) at DIAGNOSIS3.7Maximum size of lesion on pre-operative imaging AFTER neoadjuvant therapy (if used) and pre-surgery (mm) x (mm)3.8FocalityUnifocal – one lesionMultifocal – two distinct separate lesions with apparently normal breast tissue between them3.9Contralateral symmetrisation1. Planned at same time as TM2. Planned for a later date3. Patient does not want symmetrisation3.10What other treatment options were offered to the patient? (please tick all that apply)1. Standard wide local excision2. Mastectomy alone3.Mastectomy with immediate implant-based breast reconstruction4.Mastectomy with immediate autologous breast reconstruction3.11Indications for therapeutic mammaplasty (please tick all that apply)1. To avoid mastectomy2.To avoid poor cosmetic outcome associated with standard wide local excision3.To avoid problems associated with radiotherapy in patients with large breasts4.Large tumour5.Quality of life benefits6. Other (free text)Operative dataDate of procedureASA grade (I-IV) Name of consultant surgeon Duration of procedure (knife to skin to dressings on) in minutes Procedure performed on rightNoneTherapeutic mammaplastyReduction/mastopexy for symmetrisation Mastectomy aloneMastectomy and implant-based breast reconstructionMastectomy and autologous breast reconstructionOther (free text)Procedure performed on leftNoneTherapeutic mammaplastyReduction/mastopexy for symmetrisation Mastectomy aloneMastectomy and implant-based breast reconstructionMastectomy and autologous breast reconstructionOther (free text)The following data will be collected for each TM procedure performed. The fields will self-populate or collapse as appropriate. Right breast – TM datasetGrade of operating surgeon (consultant/associate specialist/senior trainee/junior trainee/other)Number of therapeutic mammoplasties performed using this method in total (supervised and unsupervised)Number of therapeutic mammoplasties performed using this method unsupervised (<5, 5-10, 10-25, >25)Pre-operative localisation yes/noIf yes – bracketed yes/noNipple preserved (yes/no/free nipple graft)Skin incision usedPeri or circumareolar with skin excision (round block/Benelli/Racquet)Wise-pattern/Inverted TSingle vertical scar/LeJourGrisotti – for central cancers removing nippleMelon slice or horizontal wedge excision (+/- nipple)OtherPedicle(s) used to preserve the nipple (if nipple preserved)SuperiorSuperiomedialMedialInferiorCentral moundDual pedicleOtherHow was tumour excised?Wide local excision performed first, specimen removed followed by the reduction/mastopexyWide local specimen incorporated in reduction specimen – both procedures performed simultaneouslyIntraoperative confirmation of excisionNoneSpecimen X-rayIntra-operative frozen sectionMargin probe/iKnife/intraoperative technology OtherVolume of wide local excision (grams)Total volume of breast tissue excised (wide local excision + all excised breast tissue) (grams)Method of marking tumour bed (None/Single clip/Clips to all margins)Axillary surgery performed (None/sentinel node/clearance)Drains used (yes/no)Right breast (reduction dataset)Grade of operating surgeon (consultant/associate specialist/senior trainee/junior trainee/other)Number of reductions performed using this method in total (supervised and unsupervised)Number of reductions performed using this method unsupervised (<5, 5-10, 10-25, >25)Skin incision usedPeri or circumareolar with skin excision (round block/Benelli/Racquet)Wise-pattern/Inverted TSingle vertical scar/LeJourMelon slice or horizontal wedge excision (+/- nipple)OtherPedicle(s) used to preserve the nipple (if nipple preserved)SuperiorSuperiomedialMedialInferiorCentral moundDual pedicleOtherTotal volume of breast tissue excised (wide local excision + all excised breast tissue) (grams)Drains used (yes/no)Left breast – TM datasetGrade of operating surgeon (consultant/associate specialist/senior trainee/junior trainee/other)Number of therapeutic mammoplasties performed using this method in total (supervised and unsupervised)Number of therapeutic mammoplasties performed using this method unsupervised (<5, 5-10, 10-25, >25)Pre-operative localisation yes/noIf yes – bracketed yes/noNipple preserved (yes/no/free nipple graft)Skin incision usedPeri or circumareolar with skin excision (round block/Benelli/Racquet)Wise-pattern/Inverted TSingle vertical scar/LeJourGrisotti – for central cancers removing nippleMelon slice or horizontal wedge excision (+/- nipple)OtherPedicle(s) used to preserve the nipple (if nipple preserved)SuperiorSuperiomedialMedialInferiorCentral moundDual pedicleOtherHow was tumour excised?Wide local excision performed first, specimen removed followed by the reduction/mastopexyWide local specimen incorporated in reduction specimen – both procedures performed simultaneouslyIntraoperative confirmation of excisionNoneSpecimen X-rayIntra-operative frozen sectionMargin probe/iKnife/intraoperative technology OtherVolume of wide local excision (grams)Total volume of breast tissue excised (wide local excision + all excised breast tissue) (grams)Method of marking tumour bed (None/Single clip/Clips to all margins)Axillary surgery performed (None/sentinel node/clearance)Drains used (yes/no)Left breast (reduction dataset)Grade of operating surgeon (consultant/associate specialist/senior trainee/junior trainee/other)Number of reductions performed using this method in total (supervised and unsupervised)Number of reductions performed using this method unsupervised (<5, 5-10, 10-25, >25)Skin incision usedPeri or circumareolar with skin excision (round block/Benelli/Racquet)Wise-pattern/Inverted TSingle vertical scar/LeJourMelon slice or horizontal wedge excision (+/- nipple)OtherPedicle(s) used to preserve the nipple (if nipple preserved)SuperiorSuperiomedialMedialInferiorCentral moundDual pedicleOtherTotal volume of breast tissue excised (wide local excision + all excised breast tissue) (grams)Drains used (yes/no)Pathology and post-operative MDT outcomesTo be collected for each side from which TM was performedRight breast5.1Invasive/DCIS5.2Grade5.3One tumour (unifocal)/ 2 or more separate lesions5.4Size of invasive tumour (mm) (largest if >1)5.5Total size of lesion including DCIS (mm)5.6Fully excised by local criteria? (yes/no)5.7Number of lymph nodes involved (macromets only)5.8ER status (positive/negative/not known)5.9HER-2 status (positive/negative/not known)If not fully excised:5.10MDT decision1. Re-excision of margins2.Mastectomy3.Chemotherapy followed by re-excision of margins4.Chemotherapy followed by mastectomy +/- reconstructionRe-excision 15.11Date of surgery5.12Surgery performed (re-excision of margins/completion mastectomy+/- reconstruction)5.13Specimen weight (g)5.14Margins clear (yes/no)Re-excision 25.15Date of surgery5.16Surgery performed (re-excision of margins/completion mastectomy =/- reconstruction)5.17Specimen weight (g)5.18Margins clear (yes/no)Re-excision 35.19Date of surgery5.20Surgery performed (re-excision of margins/completion mastectomy +/- reconstruction)5.21Specimen weight (g)5.22Margins clear (yes/no)5.23Chemotherapy recommended by MDTYes/No/ Neoadjuvant chemo already givenIf yes5.24Date of recommendation5.25Patient accepts chemotherapy yes/no5.26Date of commencement of treatment 5.27Radiotherapy recommended by MDTYes/NoIf yes5.28Date of recommendation5.29Boost to tumour bed (yes/no)5.30Date of commencement of treatment 30 day complication data (from date of initial TM surgery) – data for right and left breasts to be collected separately6.1Seroma requiring aspiration (right/left/no) 6.2Haematoma6.2.1Major (surgical drainage) (right/left/no) 6.2.2Minor (conservative management) (right/left/no) 6.3Wound infection 6.3.1Minor (oral Abx) (right/left/no) 6.3.2Major 1 (IV Abx) (right/left/no) 6.3.3Major 2 (surgical drainage +/- debridement) (right/left/no) 6.4Skin necrosis – including T junction necrosis6.4.1Minor (conservative management) (right/left/no) 6.4.2Major (requiring surgical debridement) (right/left/no) 6.5Nipple necrosis 6.5.1Minor (conservative management) (right/left/no) 6.5.2Major I (requiring debridement) (right/left/no) 6.5.3Major II (complete NAC loss) (right/left/no) 6.6Wound dehiscence6.6.1Minor – managed conservatively 6.6.2Major – requiring return to theatre6.7In-hospital complication including systemic complications e.g. DVT/PE at time of initial surgery (yes/no with details)6.8Readmission to hospital within 30 days (yes/no with reason)6.9Re-operation for complication within 30 days (yes/no with reason)6.10Initial length of stay (day-case/23 hour stay/inpatient)7.Data validation and quality assuranceFollowing data collection, only data sets with >95% data completeness will be included in the analysis ADDIN EN.CITE <EndNote><Cite><Author>Vohra</Author><Year>2015</Year><RecNum>2255</RecNum><DisplayText><style face="superscript">31</style></DisplayText><record><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1455467414">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Vohra, Ravinder S</author><author>Spreadborough, Philip</author><author>Johnstone, Marianne</author><author>Marriott, Paul</author><author>Bhangu, Aneel</author><author>Alderson, Derek</author><author>Morton, Dion G</author><author>Griffiths, Ewen A</author></authors></contributors><titles><title>Protocol for a multicentre, prospective, population-based cohort study of variation in practice of cholecystectomy and surgical outcomes (The CholeS study)</title><secondary-title>BMJ Open</secondary-title></titles><periodical><full-title>BMJ Open</full-title></periodical><volume>5</volume><number>1</number><dates><year>2015</year><pub-dates><date>January 1, 2015</date></pub-dates></dates><urls><related-urls><url>. For quality assurance purposes, the Consultant principal investigator at selected sites will be asked to identify an independent person to validate a proportion of the submitted data. Overall, approximately 5% of the datasets will be independently validated. The independent assessors will also be asked to examine theatre logbooks, operating diaries and Trust computer systems to check case ascertainment. HES data will also be used for this purpose. If concordance between the number of cases submitted on REDcap and those identified independently is <90%, the Unit’s data will be excluded from the analysis. This is consistent with the quality assurance procedure used in other large collaborative audit projects ADDIN EN.CITE <EndNote><Cite><Author>Vohra</Author><Year>2015</Year><RecNum>2255</RecNum><DisplayText><style face="superscript">31</style></DisplayText><record><rec-number>2255</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1455467414">2255</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Vohra, Ravinder S</author><author>Spreadborough, Philip</author><author>Johnstone, Marianne</author><author>Marriott, Paul</author><author>Bhangu, Aneel</author><author>Alderson, Derek</author><author>Morton, Dion G</author><author>Griffiths, Ewen A</author></authors></contributors><titles><title>Protocol for a multicentre, prospective, population-based cohort study of variation in practice of cholecystectomy and surgical outcomes (The CholeS study)</title><secondary-title>BMJ Open</secondary-title></titles><periodical><full-title>BMJ Open</full-title></periodical><volume>5</volume><number>1</number><dates><year>2015</year><pub-dates><date>January 1, 2015</date></pub-dates></dates><urls><related-urls><url> management and storageData collection will occur in accordance with Caldicott II principles. Data for each patient will be anonymised using a unique alphanumeric study identification number. No patient identifiable data will be recorded for the purpose of the audit.Study data will be collected and managed using REDCap electronic data capture tools hosted at University of Oxford ADDIN EN.CITE <EndNote><Cite><Author>Harris</Author><Year>2009</Year><RecNum>2084</RecNum><DisplayText><style face="superscript">30</style></DisplayText><record><rec-number>2084</rec-number><foreign-keys><key app="EN" db-id="rdvrrtrridzzaoertemv5xrmdzxr9e9frtp2" timestamp="1397393422">2084</key></foreign-keys><ref-type name="Journal Article">17</ref-type><contributors><authors><author>Harris, Paul A.</author><author>Taylor, Robert</author><author>Thielke, Robert</author><author>Payne, Jonathon</author><author>Gonzalez, Nathaniel</author><author>Conde, Jose G.</author></authors></contributors><titles><title>Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support</title><secondary-title>Journal of Biomedical Informatics</secondary-title></titles><periodical><full-title>Journal of Biomedical Informatics</full-title></periodical><pages>377-381</pages><volume>42</volume><number>2</number><section>377</section><dates><year>2009</year></dates><urls></urls><electronic-resource-num>. REDCap (Research Electronic Data Capture) is a secure, web-based application designed to support data capture for research studies, providing 1) an intuitive interface for validated data entry; 2) audit trails for tracking data manipulation and export procedures; 3) automated export procedures for seamless data downloads to common statistical packages; and 4) procedures for importing data from external sources. 9.Sample size and data analysis All data analysis will occur centrally and will be led by TeaM Study Steering Group with support from statisticians and methodologists at the Bristol Surgical Trials Centre. 9.1HES AnalysisHES data will be analysed using simple summary statistics. Data will be tested for distribution and variation in the number of procedures performed over time and mastectomy rates compared using unpaired t-tests, Mann-Whitney U tests and Chi squared tests as appropriate. 9.2Prospective audit9.2.1Sample size Data regarding the numbers of TM procedures performed nationally is lacking. Publications of single centre case-series, however, suggest that 10 and 20 procedures per year may represent a reasonable estimate of volume per centre. It is anticipated that the majority of the 144 breast units in the UK will offer the procedure to their patients. Based on experience from the iBRA study, it may be anticipated that 40% of units will chose to participate in the audit. Complication rates in the literature range from 10-91% with a median of 23%. Using these figures, taking 15 procedures per year as an estimate of volume per centre, we estimate that we will have a sample size around 432 (15 procedures, multiplied by 144 centres, multiplied by 0.4 to take account of unit participation, divided by 2 due to the use of half a year's recruitment) with recruitment for half a year. Using the median complication rate from the literature we would estimate around 99 adverse outcomes.9.2.2Data analysisSimple summary statistics will be calculated for each outcome and regression analysis used to control for predictive variables. Data will be tested for distribution and differences between groups using unpaired t-tests, Mann-Whitney U tests and Chi squared tests as appropriate. Exploratory analyses will be performed to explore predictors for adverse outcomes and generate hypotheses for future studies.Summary statistics will be calculated for each participating Trust and fed back to individual units to allow comparison with national averages and ranges.Full details of the analysis can be found in the Statistical Analysis Plan (SAP).10. Publication and authorship policy The TeaM Study Steering Group which will be responsible for drafting manuscripts and preparing them for publication. All publications from this project will be ‘on behalf of the Therapeutic Mammaplasty (TeaM) Study Group and the Mammary Fold Academic and Research Collaborative’. The International Committee of Medical Journal Editors (ICMJE) criteria () for authorship is based on the following four criteria:Substantial contribution to the conception or design of the work; or the acquisition, analysis or interpretation of the data for the work andDrafting the work or revising it critically for important intellectual content andFinal approval of the version to be published andAgreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.The ICMJE states ‘when submitting a manuscript authored by a group, the corresponding author should specify the group name if one exists and clearly identify the group members who can take credit and responsibility for the work as authors. The byline of the article identifies who is directly responsible for the manuscript and MEDLINE lists authors whichever names appear on the byline. If the byline includes a group name, MEDLINE will list the names of individual group members who are authors or who are collaborators, sometimes called non-author contributors, if there is a note associated with the byline clearly stating that the individual names are elsewhere in the paper and whether those names are authors or collaborators.’All citable collaborators will therefore be listed at the end of the paper and their roles identified. 10.1 Criteria for citable collaborators statusCitable collaborators will have been required to make considerable contribution to the study. These will include leads at each centre and other team members (including consultant surgeons, SAS doctors, clinical nurse specialists or research nurses) who have recruited at least 5 patients to the study. Recruitment in this context includes the submission of at least five completed data sets. Judgement may be used to determine participation according to local centre practice. Unit leads will be asked to provide details of their local team and whether individuals fulfil the criteria for citable or acknowledged collaborator status.10.2 Acknowledged collaboratorsAcknowledged collaborators will include consultant surgeons who contributed patients to the audit, but did not personally collect data and trainees who have made a lesser contribution to patient recruitment and data collection than that required for citable collaborator status. Trainees who are acknowledged contributors will also receive a certificate of participation for inclusion in their portfolios. Local collaboratives and hospital Trusts will have ownership of their own data and will be able to present it locally if they wish.11. Research Governance The main aim of the audit is to determine the safety of therapeutic mammaplasty.Data will be analysed at the end of the study period to determine mean complication and re-excision rates. These figures will be used for benchmarking and to determine acceptable complication parameters for the audit (mean +/- 3 standard deviations as per original NMBRA). Outcome data for each individual centre and/or surgeon (depending on number of patients recruited) will be calculated, compared with the national average and fed back to participating units. 12. Study ManagementOversight of the audit will be by the TeaM Audit Steering Group which will have wide representation from reconstructing surgeons, trainees, the professional societies, patient representative and those with experience of study management and statistics. This group is expected to meet twice per year, but may also meet more frequently if necessary.There will in addition be a smaller executive group for day to day audit management. It is expected that most of this work will be done as a ‘virtual group’ by e mail.13.Study timelineThe following study time line is proposedHES analysisFeb – May 20163 centre pilot studyApril 2016 onwardsRegistration of interest from breast unitsFeb –September 2016Local audit approvals in participating unitsFebruary-September 2016**** All units must have registered, obtained local audit approvals for study participation and sent a copy of the form/email confirming audit approvals to the MFAC by the study start date 5th September 2016****Patient recruitment Patients with TM operation dates between 5th September 2016 – 10th February 2017 inclusiveData collection period5th September 2016- 12th March 2017 (allowing for 30 day FU)Closing date for data submission 31St March 2017Data analysisApril-May 2017Write up and disseminationJune/July 2017Design of prospective cohort study and grant submissionSept-Dec 2017Gantt Chart for TeaM Study 20162017FMAMJJASONDJFMAMJJASONDPhase 1 HES Data Analysis StudyRegistrations of interest and local audit approvals obtained3 centre prospective audit pilot studyNational patient recruitment and data collection5th September 2016 – 10th February 2017Data cleaning andanalysisWrite up & disseminationDesign of Prospective cohort study and funding submission13.References ADDIN EN.REFLIST 1.Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer. New England Journal of Medicine 2002;347(16): 1233-1241.2.Veronesi U, Cascinelli N, Mariani L, Greco M, Saccozzi R, Luini A, Aguilar M, Marubini E. Twenty-Year Follow-up of a Randomized Study Comparing Breast-Conserving Surgery with Radical Mastectomy for Early Breast Cancer. N Engl J Med 2002;347(16): 1227-1232.3.Haloua M, Krekel N, Jacobs G, Zonderhuis B, Bouman M, Buncamper M, Niessen F, HAH W, Terwee C, Meijer S, van den Tol M. Cosmetic assessment following breast conserving therapy: A comparison between BCCT.core software and panel evaluation. International Journal of Breast Cancer 2014;Article ID 716860.4.Cochrane RA, Valasiadou P, Wilson ARM, Al-Ghazal SK, Macmillan RD. Cosmesis and satisfaction after breast-conserving surgery correlates with the percentage of breast volume excised. British Journal of Surgery 2003;90(12): 1505-1509.5.McCulley SJ, Macmillan RD. Planning and use of therapeutic mammaplasty—Nottingham approach. British Journal of Plastic Surgery 2005;58(7): 889-901.6.Macmillan D, James R, Gale K, McCulley SJ. Therapeutic mammaplasty. Journal of Surgical Oncology 2014;110: 90-95.7.Mansfield L, Agrawal A, Cutress RI. Oncoplastic breast conserving surgery. Gland Surgery 2013;2(3): 158-162.8.Piper M, Peled AW, Sbitany H. Oncoplastic breast surgery: current strategies. Gland Surgery 2015;4(2): 154-163.9.Bamford R, Sutton R, McIntosh J. Therapeutic mammaplasty allows for clear surgical margins in large and multifocal tumours without delaying adjuvant therapy. The Breast 2015;24(2): 171-174.10.Schaverien MV, Raine C, Majdak-Paredes E, Dixon JM. Therapeutic mammaplasty – Extending indications and achieving low incomplete excision rates. European Journal of Surgical Oncology (EJSO) 2013;39(4): 329-333.11.McIntosh J, O'Donoghue JM. Therapeutic mammaplasty--a systematic review of the evidence. Eur J Surg Oncol 2012;38(3): 196-202.12.Harvey J, Henderson J, Patel L, Murphy J, Johnson R. Therapeutic mammaplasty – Impact on the delivery of chemotherapy. International Journal of Surgery 2014;12(1): 51-55.13.Kahn J, Barrett S, Forte C, Stallard S, Weiler-Mithoff E, Doughty JC, Romics Jr L. Oncoplastic breast conservation does not lead to a delay in the commencement of adjuvant chemotherapy in breast cancer patients. European Journal of Surgical Oncology (EJSO) 2013;39(8): 887-891.14.Schaverien MV, Doughty JC, Stallard S. Quality of information reporting in studies of standard and oncoplastic breast-conserving surgery. The Breast 2014;23(2): 104-111.15.Haloua MH, Krekel NM, Winters HA, Rietveld DH, Meijer S, Bloemers FW, van den Tol MP. A systematic review of oncoplastic breast-conserving surgery: current weaknesses and future prospects. Ann Surg 2013;257(4): 609-620.16.Bhangu A, Kolias AG, Pinkney T, Hall NJ, Fitzgerald JE. Surgical research collaboratives in the UK. The Lancet 2013;382(9898): 1091-1092.17.Dowswell G, Bartlett D, Futaba K, Whisker L, Pinkney T, on behalf of West Midlands Research Collaborative B, UK. How to set up and manage a trainee-led research collaborative. BMC Medical Education 2014;14(1): 94.18.The UK National Surgical Research Collaborative. Safety of Short, In-Hospital Delays Before Surgery for Acute Appendicitis: Multicentre Cohort Study, Systematic Review, and Meta-Analysis. Annals of Surgery 2014;Publish Ahead of Print: 10.1097/SLA.0000000000000492.19.Ferguson HJ, Hall NJ, Bhangu A, on behalf of the National Surgical Research Collaborative. A multicentre cohort study assessing day of week effect and outcome from emergency appendicectomy. BMJ Quality & Safety 2014.20.National Surgical Research Collaborative. Multicentre observational study of performance variation in provision and outcome of emergency appendicectomy. British Journal of Surgery 2013;100(9): 1240-1252.21.Bhangu A, Futaba K, Patel A, Pinkney T, Morton D. Reinforcement of closure of stoma site using a biological mesh. Techniques in Coloproctology 2013: 1-4.22.Pinkney TD, Calvert M, Bartlett DC, Gheorghe A, Redman V, Dowswell G, Hawkins W, Mak T, Youssef H, Richardson C, Hornby S, Magill L, Haslop R, Wilson S, Morton D. Impact of wound edge protection devices on surgical site infection after laparotomy: multicentre randomised controlled trial (ROSSINI Trial). BMJ 2013;347.23.Potter S, Holcombe C, Mylvaganam S, Thrush S, Whisker L, Skillman J. The iBRA study: A national multicentre audit of the outcomes of implant-based breast reconstruction with and without lower pole support. Journal of Plastic, Reconstructive & Aesthetic Surgery 2014;67(10): 1467-1468.24.Potter S, Holcombe C, Mylvaganam S, Thrush S, Whisker L, Skillman J. 442. The iBRA Study: A national multicentre audit of the practice and outcomes of implant-based breast reconstruction. European Journal of Surgical Oncology (EJSO) 2014;40(11): S168-S169.25.National Institute of Clinical Excellence. Breast cancer (early & locally advanced): diagnosis and treatment, 2009.26.Rainsbury D, Willett A. Oncoplastic Breast Reconstruction: Guidelines for Best Practice: ABS and BAPRAS; 2012.27.Association of Breast Surgery at BASO. Surgical guidelines for the management of breast cancer. European Journal of Surgical Oncology (EJSO) 2009;35, Supplement 1: S1-S22.28.Grisotti A. Immediate reconstruction after partial mastectomy. Operative Techniques in Plastic and Reconstructive Surgery 1994;1(1): 1-12.29.Obeid JS, McGraw CA, Minor BL, Conde JG, Pawluk R, Lin M, Wang J, Banks SR, Hemphill SA, Taylor R, Harris PA. Procurement of shared data instruments for Research Electronic Data Capture (REDCap). Journal of Biomedical Informatics 2013;46(2): 259-265.30.Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support. Journal of Biomedical Informatics 2009;42(2): 377-381.31.Vohra RS, Spreadborough P, Johnstone M, Marriott P, Bhangu A, Alderson D, Morton DG, Griffiths EA. Protocol for a multicentre, prospective, population-based cohort study of variation in practice of cholecystectomy and surgical outcomes (The CholeS study). BMJ Open 2015;5(1).32.Duxbury PJ, Gandhi A, Kirwan CC, Jain Y, Harvey JR. Current attitudes to breast reconstruction surgery for women at risk of post-mastectomy radiotherapy: A survey of UK breast surgeons. The Breast 2015;24(4): 502-512. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related searches
- plastic reconstructive surgery journal
- plastic reconstructive surgery associates
- indy time trials on tv
- reconstructive plastic surgery procedures
- plastic and reconstructive surgery journal
- dental implant trials open
- dental implants clinical trials 2019
- dental trials and studies
- plastic surgery reconstructive journal
- reconstructive surgery after mastectomy
- reconstructive surgery after breast cancer
- reconstructive breast surgery options